Breast Articles From 2023: Informing Practice Across the Continuum of Care

Tari A King; Elizabeth A Mittendorf

doi:10.1245/s10434-024-15387-6

Breast Articles From 2023: Informing Practice Across the Continuum of Care

Ann Surg Oncol. 2024 May 11. doi: 10.1245/s10434-024-15387-6. Online ahead of print.

Authors

Tari A King^{1

2

3}, Elizabeth A Mittendorf^{4

5

6}

Affiliations

¹ Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. tking7@bwh.harvard.edu.
² Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. tking7@bwh.harvard.edu.
³ Harvard Medical School, Boston, MA, USA. tking7@bwh.harvard.edu.
⁴ Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
⁵ Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
⁶ Harvard Medical School, Boston, MA, USA.

PMID: 38734863
DOI: 10.1245/s10434-024-15387-6

Abstract

With new investigations and clinical trials in breast oncology reported every year, it is critical that surgeons be aware of advances and insights into the evolving care paradigms and treatments available to their patients. This article highlights five publications found to be particularly impactful this past year. These articles report on efforts to select the minimal effective dose of tamoxifen for prevention, to challenge the existing age-based screening guidelines as they relate to race and ethnicity, to refine axillary management treatment standards, to optimize systemic therapy in multidisciplinary care settings, and to reduce the burden of breast cancer-related lymphedema after treatment. Taken together, these efforts have an impact on all facets of the continuum of care from prevention and screening through treatment and survivorship.

Keywords: Axillary surgery; Breast cancer; Low dose tamoxifen; Lymphedema; Screening.